Integrated BioPharma (OTCMKTS:INBP) Trading 8.8% Higher – Here’s What Happened

Integrated BioPharma Inc. (OTCMKTS:INBP) was up 8.8% during trading on Monday . The stock traded as high as $0.31 and last traded at $0.31. Approximately 11,028 shares were traded during trading, a decline of 54% from the average daily volume of 23,854 shares. The stock had previously closed at $0.2850.

Integrated BioPharma Price Performance

The business’s fifty day moving average price is $0.31 and its 200 day moving average price is $0.30. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.12 and a quick ratio of 1.92. The stock has a market cap of $9.60 million, a P/E ratio of 31.03 and a beta of 0.47.

Integrated BioPharma (OTCMKTS:INBP) last announced its quarterly earnings results on Tuesday, September 23rd. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $14.18 million for the quarter. Integrated BioPharma had a net margin of 1.26% and a return on equity of 3.32%.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.